{"disease":{"id":"multiple-myeloma-bone-lesions","name":"multiple myeloma bone lesions"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01345019","title":"Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1718,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT06838065","title":"Rehabilitation Management for Patients with Multiple Myeloma","phase":"","overall_status":"COMPLETED","enrollment_count":128,"lead_sponsor_name":"Azienda USL Reggio Emilia - IRCCS","has_results":false},{"nct_id":"NCT07388147","title":"Exercise Therapy for Multiple Myeloma Patients","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":71,"lead_sponsor_name":"University Hospital Heidelberg","has_results":false},{"nct_id":"NCT07026799","title":"Feasibility, Safety and Effectivity of an Exercise Intervention for Newly Diagnosed Multiple Myeloma Patients During Induction Therapy","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":50,"lead_sponsor_name":"University Hospital Heidelberg","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}